Episode 260 - Carmine Stengone - President & CEO of Contineum Therapeutics`
From The BioHub - by Avetix · · 24 min
This plays from the publisher's own server. We do not host a copy.
Description
In this episode of The BioHub by Avetix, I’m joined by Carmine Stengone, President & CEO of Contineum Therapeutics.
Carmine began his career as an organic chemist before realising that his biggest impact might come outside the lab. That decision led him into business development, venture, company building and eventually the CEO seat.
We discuss why he joined Contineum, the thinking behind PIPE-791, the company’s work in pulmonary fibrosis, taking Contineum public in 2024, and the challenge of balancing public-market expectations with the much longer timelines of drug development.
Carmine also shares the mentors who shaped his career, the lessons he’s learned building biotech companies, and what comes next for Contineum.